Financial Ratios | Laurus Labs Ltd. | R Wadiwala Securities Pvt Ltd

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE1014.90-3.2 (-0.31 %)
PREV CLOSE (Rs.) 1018.10
OPEN PRICE (Rs.) 1016.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 216228
TODAY'S LOW / HIGH (Rs.)1006.00 1027.60
52 WK LOW / HIGH (Rs.)504.3 1040
NSE1012.30-7 (-0.69 %)
PREV CLOSE( Rs. ) 1019.30
OPEN PRICE (Rs.) 1016.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1012.30 (94)
VOLUME 1244218
TODAY'S LOW / HIGH(Rs.) 1006.10 1027.50
52 WK LOW / HIGH (Rs.)501.15 1040.2

Financial Ratios

Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)6.642.9314.5615.4018.33
   CEPS(Rs)14.5510.2620.8120.1722.16
   DPS(Rs)1.200.802.002.002.00
   Book NAV/Share(Rs)82.4675.8874.7362.1948.32
   Tax Rate(%)26.8228.8328.1623.2024.39
Margin Ratios
   Core EBITDA Margin(%)19.0015.4226.3628.8232.22
   EBIT Margin(%)12.618.3221.0924.0328.45
   Pre Tax Margin(%)8.724.6918.3621.9627.03
   PAT Margin (%)6.383.3413.1916.8720.44
   Cash Profit Margin (%)14.1310.9718.5521.9624.70
Performance Ratios
   ROA(%)4.002.1010.8913.0920.87
   ROE(%)8.304.1521.6328.0545.15
   ROCE(%)10.166.6422.9725.9739.82
   Asset Turnover(x)0.630.630.830.781.02
   Sales/Fixed Asset(x)0.930.971.411.461.78
   Working Capital/Sales(x)7.016.985.877.447.79
Efficiency Ratios
   Fixed Capital/Sales(x)1.071.040.710.690.56
   Receivable days120.60117.4288.6698.3779.52
   Inventory Days124.27127.81104.09123.3494.05
   Payable days153.14135.42106.10175.76155.37
Valuation Parameters
   PER(x)92.37133.9020.1238.3119.75
   PCE(x)42.1938.1914.0829.2516.34
   Price/Book(x)7.445.163.929.497.49
   Yield(%)0.200.200.680.340.55
   EV/Net Sales(x)6.424.662.936.764.33
   EV/Core EBITDA(x)31.5429.2111.0823.2013.23
   EV/EBIT(x)50.9056.0013.9028.1215.21
   EV/CE(x)4.973.552.954.793.62
   M Cap / Sales5.964.192.616.424.04
Growth Ratio
   Net Sales Growth(%)10.18-16.5522.392.5469.99
   Core EBITDA Growth(%)40.62-49.7011.16-8.68175.97
   EBIT Growth(%)67.03-67.097.41-13.37257.33
   PAT Growth(%)110.69-78.89-4.30-15.39285.40
   EPS Growth(%)127.12-79.91-5.42-15.98-23.23
Financial Stability Ratios
   Total Debt/Equity(x)0.610.610.490.520.56
   Current Ratio(x)1.221.231.421.251.25
   Quick Ratio(x)0.680.640.730.590.61
   Interest Cover(x)3.242.297.7111.5920.09
   Total Debt/Mcap(x)0.080.120.120.050.07